BCA
AKCA

Berman Capital Advisors’s Akcea Therapeutics Inc AKCA Stock Holding History

Berman Capital Advisors’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-62
Closed -$1K – 1914
2020
Q3 		$1K Sell
62
-6
-9% -$85 ﹤0.01% 1569
2020
Q2 		$0 Buy
+68
New +$1.05K ﹤0.01% 1926

Berman Capital Advisors's AKCA Position: Q4 2020 in Review

Berman Capital Advisors sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 62 shares — an estimated $1K sold.

Berman Capital Advisors first reported a position in AKCA in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Berman Capital Advisors reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Berman Capital Advisors sold 62 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1K.
  • Berman Capital Advisors first reported a position in Akcea Therapeutics Inc in Q2 2020 and held it in 2 quarters.
  • Berman Capital Advisors's Akcea Therapeutics Inc position peaked at $1K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Berman Capital Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.